Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.neulandlabs.com | |
Market Cap | 4,575.84 Cr. | |
Enterprise Value(EV) | 4,638.25 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 167.91 | Trailing Twelve Months Ending 2023-06 |
Price-Earning Ratio (PE) | 21.24 | Trailing Twelve Months Ending 2023-06 |
Industry PE | 37.95 | Trailing Twelve Months Ending 2023-06 |
Book Value / Share | 822.35 | Trailing Twelve Months Ending 2023-06 |
Price to Book Value | 4.34 | Calculated using Price: 3,566.05 |
Dividend Yield | 0.28 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.28 Cr. | 12,829,889 Shares |
FaceValue | 10 | |
About Neuland Laboratories Ltd. | ||
Neuland is a quality conscious, research driven, reliable source of active pharmaceutical ingredients. Neuland has two world-class API manufacturing facilities close to the city of Hyderabad, capable in handling complex and hazardous reactions. Safety aspects have been given utmost significance may it be plant installation, equipment, systems and personnel to ensure smooth productivity. Dedicated team of manufacturing with incorporation of latest production techniques guarantees delivery of latest intermediate and product to our customers across the globe. |
1 Day |
|
-0.56% |
1 Week |
|
-3.52% |
1 Month |
|
-6.91% |
3 Month |
|
+28.22% |
6 Month |
|
+115.74% |
1 Year |
|
+148.54% |
2 Year |
|
+126.39% |
5 Year |
|
+378.29% |
10 Year |
|
+1596.77% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 11.24 | 15.64 | 22.34 | 5.02 | 3.48 | 2.30 | 10.79 | 7.85 | 17.84 | |
Return on Capital Employed (%) | 15.75 | 18.57 | 15.98 | 4.07 | 3.99 | 7.85 | 12.81 | 9.44 | 20.94 | |
Return on Assets (%) | 3.20 | 5.23 | 6.65 | 1.23 | 1.49 | 1.37 | 6.31 | 4.71 | 11.04 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Shh. Funds | 124 | 161 | 187 | 546 | 558 | 699 | 710 | 786 | 841 | 994 | |
Non Curr. Liab. | 52 | 55 | 69 | 54 | 146 | 104 | 163 | 170 | 180 | 147 | |
Curr. Liab. | 307 | 295 | 268 | 286 | 367 | 327 | 358 | 369 | 363 | 439 | |
Minority Int. | 0 | 0 | |||||||||
Equity & Liab. | 483 | 512 | 524 | 886 | 1,071 | 1,130 | 1,231 | 1,325 | 1,383 | 1,580 | |
Non Curr. Assets | 196 | 196 | 210 | 511 | 624 | 677 | 716 | 775 | 803 | 819 | |
Curr. Assets | 288 | 316 | 314 | 375 | 447 | 453 | 515 | 550 | 581 | 761 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 483 | 512 | 524 | 886 | 1,071 | 1,130 | 1,231 | 1,325 | 1,383 | 1,580 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-06 Rs. Cr. TTM |
Net Sales | 469 | 510 | 579 | 527 | 667 | 763 | 937 | 951 | 1,191 | 1,333 | |
Other Income | 1 | 2 | 1 | 5 | 3 | 4 | 16 | 2 | 10 | 11 | |
Total Income | 470 | 512 | 580 | 532 | 670 | 767 | 953 | 953 | 1,201 | 1,344 | |
Total Expenditure | -403 | -430 | -473 | -477 | -608 | -661 | -790 | -808 | -919 | -993 | |
PBIDT | 67 | 82 | 108 | 55 | 62 | 106 | 163 | 145 | 282 | 351 | |
Interest | -27 | -24 | -21 | -19 | -16 | -22 | -18 | -14 | -13 | -12 | |
Depreciation | -15 | -16 | -19 | -22 | -26 | -31 | -40 | -49 | -53 | -54 | |
Taxation | -9 | -15 | -20 | -2 | -4 | -37 | -25 | -18 | -52 | -70 | |
Exceptional Items | |||||||||||
PAT | 16 | 27 | 47 | 12 | 16 | 16 | 81 | 64 | 164 | 215 | |
Minority Interest | 0 | 0 | |||||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 16 | 27 | 47 | 12 | 16 | 16 | 81 | 64 | 164 | 215 | |
Adjusted EPS | 18 | 31 | 53 | 14 | 13 | 13 | 63 | 50 | 127 | 167 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 49 | 13 | 45 | 39 | 11 | 70 | 57 | 189 | 60 | 237 | |
Cash Fr. Inv. | -10 | -14 | -20 | -42 | -116 | -77 | -49 | -84 | -96 | -62 | |
Cash Fr. Finan. | -39 | 1 | -24 | 0 | 105 | 12 | -5 | -114 | 38 | -136 | |
Net Change | 0 | 0 | 1 | -4 | 0 | 5 | 3 | -9 | 3 | 40 | |
Cash & Cash Eqvt | 1 | 1 | 2 | 3 | 3 | 8 | 11 | 2 | 5 | 45 |
Wed, 20 Sep 2023
Loss of Share Certificates
|
|
Thu, 31 Aug 2023
Loss of Share Certificates
|
|
Wed, 30 Aug 2023
Loss of Share Certificates
|
Thu, 21 Sep 2023 |
|
|
|
|
|